3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Rhabdoid Tumor
1
Recurrence
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Interventions
Temozolomide
38
Radiotherapy
21
Radiosurgery
21
Irinotecan
11
Cyclophosphamide
11
Radiation
10
Magnetic Resonance Spectroscopy
10
Etoposide
10
Surgical Procedures, Operative
9
Erlotinib Hydrochloride
9
Carmustine
9
Filgrastim
8
Carboplatin
8
pembrolizumab
7
Bevacizumab
7
Vincristine
6
Sorafenib
6
O(6)-benzylguanine
6
Nivolumab
6
Flucytosine
6
Aminolevulinic Acid
6
temsirolimus
5
sargramostim
5
Vorinostat
5
Trastuzumab
5
Topotecan
5
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
Everolimus
5
cediranib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Brain Neoplasms
×
gallium maltolate
×
Clear all
NCT07331064
2026-01-09
GABRIEL
Medical College of Wisconsin
Phase 1
Not yet recruiting
15 enrolled